Brief: Humanigen Inc Says Anticipates That It Will Not Be Able To Continue As A Going Concern And Is Exploring All Restructuring Options

Humanigen

25/07/2023 11:11

July 25 (Reuters) - Humanigen Inc  HGEN.O :
    * HUMANIGEN INC -  ANTICIPATES THAT IT WILL NOT BE ABLE TO
CONTINUE AS A GOING CONCERN AND IS EXPLORING ALL RESTRUCTURING
OPTIONS
    * HUMANIGEN INC -  EVALUATING TERM SHEETS RELATING TO
POTENTIAL
SALES OF ASSETS IN A BANKRUPTCY PROCEEDING
    * HUMANIGEN - NEGOTIATIONS WITH PRIVATELY HELD
BIOPHARMACEUTICAL
CO RELATING TO PROPOSED DEAL, HAVE ENDED WITHOUT EXECUTION OF A
DEFINITIVE AGREEMENT
    * HUMANIGEN - HAS BEEN UNSUCCESSFUL IN ITS ATTEMPT TO
IDENTIFY AND
COMPLETE ANOTHER STRATEGIC OR EQUITY FINANCING TRANSACTION IN
THE FIRST HALF OF 2023
    * HUMANIGEN - HAS BEEN UNSUCCESSFUL IN RAISING DEBT OR
EQUITY
FINANCING IN SUFFICIENT AMOUNTS AND WITH ACCEPTABLE TERMS TO
FUND CO'S OPERATIONS GOING FORWARD
    * HUMANIGEN: ON JULY 21, CO NOTIFIED NASDAQ THAT IT DOES NOT
EXPECT TO DEMONSTRATE COMPLIANCE WITH APPLICABLE CRITERIA FOR
LISTING ON NASDAQ BY AUG 21
    * HUMANIGEN: CO RECEIVED A LETTER ON EVENING OF JULY 24,
2023
INDICATING THAT NASDAQ PANEL WILL DELIST SHARES OF COMPANY FROM
NASDAQ
    * HUMANIGEN: TRADING IN COMPANY SHARES WILL BE SUSPENDED
FROM
WEDNESDAY, JULY 26, 2023
    * HUMANIGEN: SHARES WILL COMMENCE TRADING ON OTC PINK MARKET

Source text for Eikon:  ID: 
Further company coverage:  HGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))